| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/01/1996 | CN1121733A Integrative DNA segment comprising gene encoding insecticidal protein |
| 05/01/1996 | CN1121724A Extraction of cell-bound protein from bordetella |
| 05/01/1996 | CN1121723A 因子vii的纯化 The purified factor vii |
| 05/01/1996 | CN1031714C Process for preparing urinary follicle stimulating hormone |
| 05/01/1996 | CA2161495A1 Preparation of stable insulin analog crystals |
| 04/30/1996 | US5512661 Provides for nucleic acids encoding chimeric neurotrophic factors; for targeting active compounds to cells responsive to neurotropic factor |
| 04/30/1996 | US5512660 Purified ICAM-2 and fragment thereof |
| 04/30/1996 | US5512658 Pseudomonas exotoxins (PE) and conjugates thereof having lower animal toxicity with high cytocidal activity through substitution of positively charged amino acids |
| 04/30/1996 | US5512656 Immune system modulators |
| 04/30/1996 | US5512550 Method for inhibiting angiogenesis with modified platelet factor-4 and cleaved platelet factor-4 |
| 04/30/1996 | US5512549 Antidiabetic agents |
| 04/30/1996 | US5512548 CETP inhibitor polypeptide, antibodies against the synthetic polypeptide and prophylactic and therapeutic anti-atherosclerosis treatments |
| 04/30/1996 | US5512544 Pharmaceutical compositions comprising an anticytokine |
| 04/30/1996 | US5512484 Carrot 16 KD protein, gene coding for said protein and plasmid containing said gene |
| 04/30/1996 | US5512482 Plant thioesterases |
| 04/30/1996 | US5512478 Purified dna molecules encoding protein enzymes; bioremediation |
| 04/30/1996 | US5512473 Max-interacting proteins and related molecules and methods |
| 04/30/1996 | US5512467 Acyl-peptide hydrolase and methods of production and use |
| 04/30/1996 | US5512460 Glia activating factor and its production |
| 04/30/1996 | US5512459 Transpeptization by contacting peptide and addition unit with thrombin to cleave leaving unit from core at enzyme cleavage site |
| 04/30/1996 | US5512457 Cytokine designated elk ligand |
| 04/30/1996 | US5512455 Atrial natriuretic peptide receptor protein |
| 04/30/1996 | US5512452 Detecting gene expression in microorganism during infection of host |
| 04/30/1996 | US5512447 Methods for the diagnosis and treatment of diabetes |
| 04/30/1996 | US5512444 Method for determining bladder tumors by assaying for MAGE-1,2,3 or 4 |
| 04/30/1996 | US5512442 Using specific antibody binding |
| 04/30/1996 | US5512441 Quantative method for early detection of mutant alleles and diagnostic kits for carrying out the method |
| 04/30/1996 | US5512437 Method for determining head and neck squamous cell carcinomas, prostate carcinomas, and bladder tumors by assaying for mage-3 |
| 04/30/1996 | US5512430 Diagnostic array for virus infection |
| 04/30/1996 | US5512421 Generation, concentration and efficient transfer of VSV-G pseudotyped retroviral vectors |
| 04/30/1996 | US5512304 Method of preparing a thromboplastin extract |
| 04/30/1996 | US5512288 Administering culture product from medium containing bile |
| 04/30/1996 | US5512283 Methods for the selective suppression of an immune response to dust mite der Pi |
| 04/30/1996 | US5512282 Purified immunoglobulins comprising monospecific polyclonal antibodies to shiga-like toxin obtained by innoculating bovine animal with active shiga-like toxin, recovering immunoglobulins after animal has immune response to toxin |
| 04/30/1996 | CA1338302C Therapeutic octapeptide somatostatin analogs |
| 04/30/1996 | CA1338301C Therapeutic octapeptide somatostatin analogs |
| 04/27/1996 | CA2134428A1 Neuropeptide y y2 agonist peptides |
| 04/25/1996 | WO1996012193A1 Estimation of the fragmentation pattern of collagen in body fluids and the diagnosis of disorders associated with the metabolism of collagen |
| 04/25/1996 | WO1996012190A2 Presentation of hydrophobic antigens to t-cells by cd1 molecules |
| 04/25/1996 | WO1996012185A1 Method for screening compositions |
| 04/25/1996 | WO1996012033A1 Polycystic kidney disease gene |
| 04/25/1996 | WO1996012030A1 Defective adenoviruses including a therapeutic gene and an immunoprotective gene |
| 04/25/1996 | WO1996012028A1 Production of peptides in plants as viral coat protein fusions |
| 04/25/1996 | WO1996012027A1 Method of producing a chimeric protein |
| 04/25/1996 | WO1996012023A1 A recombinant protein designated dev-1, useful in the detection of hiv, dna sequence encoding the protein, and immunoassays using the protein |
| 04/25/1996 | WO1996012022A1 Intracellular isoform of the interleukin-1 receptor antagonist |
| 04/25/1996 | WO1996012021A2 Nematode-extracted serine protease inhibitors and anticoagulant proteins |
| 04/25/1996 | WO1996012020A2 Hemoglobin receptors from neisseriae |
| 04/25/1996 | WO1996012019A2 Her4 human receptor tyrosine kinase or the epidermal growth factor receptor family |
| 04/25/1996 | WO1996012018A2 Novel immunophilins and corresponding nucleic acids |
| 04/25/1996 | WO1996012017A1 Gene participating in apoptosis |
| 04/25/1996 | WO1996012016A1 Neuronal apoptosis inhibitor protein, gene sequence and mutations causative of spinal muscular atrophy |
| 04/25/1996 | WO1996012010A1 Preparation of rep-negative aav mutants and cells which can be used therefor |
| 04/25/1996 | WO1996012009A2 Methods for engineering antigen-presenting cells |
| 04/25/1996 | WO1996012008A1 Synthesis of methylase-resistant genes |
| 04/25/1996 | WO1996011955A1 Antigen-binding fusion proteins |
| 04/25/1996 | WO1996011954A1 Tc or re radiolabelled somatostatin analogs |
| 04/25/1996 | WO1996011953A1 N-terminally chemically modified protein compositions and methods |
| 04/25/1996 | WO1996011952A1 Method for purifying keratinocyte growth factors |
| 04/25/1996 | WO1996011951A2 Keratinocyte growth factor analogs |
| 04/25/1996 | WO1996011950A1 Method of treating diabetes mellitus using kgf |
| 04/25/1996 | WO1996011949A2 Analogs of keratinocyte growth factor |
| 04/25/1996 | WO1996011948A1 Neurotrophic peptides of activity dependent neurotrophic factor |
| 04/25/1996 | WO1996011947A1 Materials for the production of nanometer structures and use thereof |
| 04/25/1996 | WO1996011946A1 Human endothelin-bombesin receptor |
| 04/25/1996 | WO1996011944A1 Synthetic peptides and vaccines comprising same |
| 04/25/1996 | WO1996011942A1 Therapeutic molecules |
| 04/25/1996 | WO1996011708A1 Membrane expression of heterologous genes |
| 04/25/1996 | WO1996011706A1 Use of flea proteases and protease inhibitors to protect animals from flea infestation |
| 04/25/1996 | WO1996011700A1 Reduction of mammalian neoplasms with phospholipase a2 activatiing substances |
| 04/25/1996 | WO1996011698A1 Allosteric modulators of the nmda receptor |
| 04/25/1996 | WO1996011696A1 Screening assay for anti-hiv drugs |
| 04/25/1996 | WO1996011695A1 Low molecular weight growth potentiating peptides |
| 04/25/1996 | WO1996011664A2 Nsk2 a muscle receptor tyrosine kinase |
| 04/25/1996 | WO1996011566A1 Gene controlling floral development and apical dominance in plants |
| 04/25/1996 | WO1996011562A2 Human checkpoint gene and gene for antisense rna thereof |
| 04/25/1996 | WO1995031541A3 Methods and compositions for treatment of restenosis and cancer using ribozymes |
| 04/25/1996 | DE4437604A1 Konjugate aus einem Poly- oder Oligopeptid und einer niedermolekularen lipophilen Verbindung Conjugates of a poly- or oligopeptide and a low molecular weight lipophilic compound |
| 04/25/1996 | CA2472085A1 N-terminally chemically modified protein compositions and methods |
| 04/25/1996 | CA2203116A1 Hemoglobin receptors from neisseriae |
| 04/25/1996 | CA2203010A1 Gene controlling floral development and apical dominance in plants |
| 04/25/1996 | CA2202761A1 Method of producing a chimeric protein |
| 04/25/1996 | CA2202680A1 Presentation of hydrophobic antigens to t-cells by cd1 molecules |
| 04/25/1996 | CA2202664A1 Preparation of rep-negative aav mutants and cells which can be used therefor |
| 04/25/1996 | CA2202628A1 Apoptosis-associated gene |
| 04/25/1996 | CA2202622A1 Use of protease inhibitors and protease vaccines to protect animals from flea infestation, and flea protease proteins, nucleic acid molecules and uses thereof |
| 04/25/1996 | CA2202533A1 Her4 human receptor tyrosine kinase |
| 04/25/1996 | CA2202474A1 Materials for the production of nanometer structures and use thereof |
| 04/25/1996 | CA2202382A1 Tc or re radiolabelled somatostatin analogs |
| 04/25/1996 | CA2202351A1 Nematode-extracted serine protease inhibitors and anticoagulant proteins |
| 04/25/1996 | CA2202283A1 Polycystic kidney disease gene |
| 04/25/1996 | CA2202048A1 Screening assay for anti-hiv drugs |
| 04/25/1996 | CA2201399A1 Defective adenoviruses including a therapeutic gene and an immunoprotective gene |
| 04/24/1996 | EP0708179A2 Glucagon-like insulinotropic peptide analogs, compositions, and methods of use |
| 04/24/1996 | EP0708178A1 Survival motor neuron (SMN) gene: a gene for spinal muscular atrophy |
| 04/24/1996 | EP0708112A1 RPDL protein and DNA encoding the same |
| 04/24/1996 | EP0707660A1 Method for generation of sequence sampled maps of complex genomes |
| 04/24/1996 | EP0707654A1 $i(BACILLUS THURINGIENSIS) TRANSPOSON Tn5401 AND ITS USE IN A SITE-SPECIFIC RECOMBINATION SYSTEM FOR $i(BACILLUS THURINGIENSIS) STRAIN DEVELOPMENT |
| 04/24/1996 | EP0707652A1 Dna coding for a peptide of a papilloma virus main capside protein and use thereof |
| 04/24/1996 | EP0707651A1 METHODS AND COMPOSITIONS FOR DETECTION OF $i(SALMONELLA) |